AXIMRIS XR Trademark

Trademark Overview


On Monday, June 23, 2025, a trademark application was filed for AXIMRIS XR with the United States Patent and Trademark Office. The USPTO has given the AXIMRIS XR trademark a serial number of 99247604. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 16, 2025. This trademark is owned by Zurich Pharma INC. The AXIMRIS XR trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery systems comprising controlled timed-release and/or targeted-release pharmaceutical formulations, provided as integral components of pharmaceutical preparations; pharmaceutical preparations incorporating such drug delivery systems in the form of oral solid dosage units, namely tablets and capsules; all for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric and gastrointestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis, and rhinitis.
aximris xr

General Information


Serial Number99247604
Word MarkAXIMRIS XR
Filing DateMonday, June 23, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2025

Trademark Statements


Goods and ServicesDrug delivery systems comprising controlled timed-release and/or targeted-release pharmaceutical formulations, provided as integral components of pharmaceutical preparations; pharmaceutical preparations incorporating such drug delivery systems in the form of oral solid dosage units, namely tablets and capsules; all for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric and gastrointestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis, and rhinitis.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 23, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZurich Pharma INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTHFIELD, MI 48075

Party NameZurich Pharma INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTHFIELD, MI 48075

Trademark Events


Event DateEvent Description
Monday, June 23, 2025NEW APPLICATION ENTERED
Monday, June 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 23, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, November 12, 2025ASSIGNED TO EXAMINER
Monday, November 17, 2025NON-FINAL ACTION WRITTEN
Monday, November 17, 2025NON-FINAL ACTION E-MAILED
Monday, November 17, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED